Preparation and application of hydrolytic acid, copolymer and 1-4-4-dimethylamine piperidin-1-il carbon-3-4-4, 6-dimorfolin-4-il-1, 3, 5-triazin-2-ilfenilurea composite containing PLA peg or PLGA peg

摘要

p This Disclosure Bertalanffy generally refers to nanopart & iacute; particles comprising a substantially hidrof ACID & nbsp; & acute; s Peak and a Therapeutic Agent & eacute; products (1 - (4 - ((4 - (dimethylamino) carbonyl] - II piperidin 1} phenyl) - 3 - [4 - (4 - dimorfolin - 4.6 - II - 1,3,5 - triazin - 2 - il) phenyl] urea), or S Pharmaceutical acceptable Salts & eacute; uticamente and pol & nbsp; grouper.Other aspects include M & eacute; all Manufacturing & amp; n and use of such nanopart & iacute; movies. / p